Sort by
Refine Your Search
-
Listed
-
Category
-
Employer
-
Field
-
are looking for an individual who can develop a PhD research project in alignment with the overarching objective of PARTY (investigating how (participatory) evaluation and learning processes can promote more
-
, optical, and anti-corrosion performance. Our investigations span nanoparticles, nanowires, lithographically patterned micro- and nano-objects, mesoporous and nanoporous structures, electrodeposited thin
-
research units participated by companies and research organisations: 1 point per month worked, up to a maximum of 20 points. Experience in previous positions related to the object of the contract: 1 point
-
student will be mainly involved in developing the activities to achieve specific objectives of the project: To develop and optimize respiratory organoids derived from relevant host/reservoir animal species
-
. Conduct fieldwork to measure physiological and biophysical variables in vineyards. Gain experience with crop models, with the main objective to predict yield. Implement computer vision techniques
-
. Objectives: This PhD project aims to design and develop advanced nanoarchitectured surface coatings for bioelectronic cutaneous interfaces (BCHIs), minimizing skin irritation and infection risks. The candidate
-
understanding of the role of forests in the water cycle. Objectives of the research: Study temporal patterns of climate and water-source related processes using stable water isotope chronologies from tree rings
-
arteriovenous malformations mitigation Description. The main objective will be to conduct bioavailability and bioaccumulation studies of pharmaceutical formulations designed to treat cerebral arteriovenous
-
career development, in the fields of academia and industry. This objective is achieved by: The performance of an individual research project under the direction of an internationally renowned Group Leader
-
the strengths and challenges of current regulatory frameworks for AI in robotic rehabilitation. Central questions include: Are AI-driven therapies objective and neutral? Will everyone have equal access